Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

42.53 -0.29 (-0.67%)
Streaming Delayed Price Updated: 3:41 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,713,005
Open 42.82
Bid (Size) 42.53 (27)
Ask (Size) 42.54 (55)
Prev. Close 42.82
Today's Range 42.52 - 43.15
52wk Range 42.75 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What to Expect from Bristol-Myers Squibb's Earnings
 
Via Benzinga
Bristol-Myers Squibb (BMY) To Report Earnings Tomorrow: Here Is What To Expect
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence

Performance

YTD
-25.1%
-25.1%
1 Month
-3.7%
-3.7%
3 Month
-9.2%
-9.2%
6 Month
-13.6%
-13.6%
1 Year
-19.2%
-19.2%

More News

Read More
3 Dividend-Paying Drug Stocks to Buy at a Discount
Via The Motley Fool
Topics Intellectual Property
Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb To Acquire Orbital Therapeutics In $1.5B Deal
Via Stocktwits
Price Over Earnings Overview: Bristol-Myers Squibb
Via Benzinga
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal
Via Benzinga
Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025
From Bristol Myers Squibb
Via Business Wire
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
Via MarketMinute
Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks
Via The Motley Fool
Topics Workforce
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
Via MarketMinute
Why Replimune Stock Was Soaring Today
Via The Motley Fool
2 High-Yield Dividend Stocks Too Cheap to Ignore
Via The Motley Fool
Topics Intellectual Property World Trade
3 S&P 500 Stocks We Find Risky
Via StockStory
Topics Stocks
This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?
Via The Motley Fool
Topics Artificial Intelligence
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
From Bristol Myers Squibb
Via Business Wire
Branded Pharmaceuticals Stocks Q2 Earnings Review: Supernus Pharmaceuticals (NASDAQ:SUPN) Shines
Via StockStory
Topics Artificial Intelligence Intellectual Property
Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition
Via Benzinga
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
From Bristol Myers Squibb
Via Business Wire
3 Value Stocks with Warning Signs
Via StockStory
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a High Dividend Yield and Strong Profitability
Via Chartmill
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Presents a Strong Value Investment Case
Via Chartmill
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Via Benzinga

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 42.53
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 10/29/25 03:41 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 94.52B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 95B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.